Useful Links :
Why Publish with us :
- » Open Access Policy
- » Flexible Online Submission
- » Preliminary Quality Report within 3 days
- » 21 days Rapid Peer-Review
- » High Quality Publication
- » Global Promotion
- » Responsive Editorial Staff
- » Globally Recognized Journals
- » 24/7 Editorial Office Availability
J Impact Factor: 1.6*
Indexing and Abstracting: Open J Gate, Genamics JournalSeek, RefSeek, EBSCO A-Z, Publons, Crossref, DOIJ, Google Scholar, PubMed (In the process of revision)
Journal of Clinical Microbiology and Immunology is an international peer-reviewed open-access journal aimed at exploring the latest developments in the field of Microbiology, Immunology, and Immunotherapy.
This journal publishes recent discoveries and current developments in the mode of research/original articles, review articles, case reports, short communications, editorials, etc. in all areas related to Clinical Microbiology, Medical Microbiology, Industrial Microbiology, Food Microbiology, Immunology, Immunotherapy, Immune System, Immunogenetics, Immunological Disorders, Immunotherapy Biomarkers, Immunobiology, Immunopharmacology, Tumour Immunity, Tumour Immunology, Cellular Immunotherapy, Rheumatology, Adaptive Immune System, Autoimmune diseases, Diagnostic Immunology, Neuroimmunology, Osteoimmunology, Cancer Immunotherapy, Cell-based Immunotherapy, Chemo Immunotherapy, Carcinogenesis, Radio Immunotherapy, Immunotherapeutic agents, Restorative Immunotherapy, Translational Immunotherapy, Immunity Enhancers, Cancer Immunology, Immune Pathology, Molecular Immunology, Immunodeficiency, Neuroinflammatory Diseases, Cellular Immunology, Antibodies, Antibiotics, etc.
No Profit-Oriented Goal Setting, No Hidden Clues
We believe a manuscript is the ultimate form of contribution of a researcher for the betterment of the global community. Impactful researches should be available to global readers with no hindrance. We never claim Publication Fees beyond the limit of the researchers.
The initial manuscript handling persons are Editorial Board Members. The decision from them will be communicated to Editor-in-Chief/Managing Editor. If assertive comments from all ends, the manuscript will go for rigorous peer-review. In all the cases stated above, only the recognized experts in the respective field will be allowed to comment on the manuscript.
The single manuscript will be assigned to multiple reviewers and the most logical and elaborated comments will be accepted for evaluation. In no condition, peer-review process will be extended more than 14 days.
Managing Editor’s Role
Managing Editor's will follow up and provide adequate responses regarding the manuscript assigned to him/her. Managing Editor’s will not interfere in the decision-making process of the manuscript. In a critical situation, the managing editor will assign the manuscript to the additional reviewer in case the review process is delayed or lack of communication with the reviewer.
Rapid and Fast Publication
All segments of the manuscript processing-related communications are transparent, rapid, and effortless which in other way helps to complete the article processing within the promised timeline.